- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07530185
Effekter af L-Tyrosin og Koffein på Præstation hos Eliteboksere (TYCAF-BOX)
Effekter af L-Tyrosin og Koffein Supplementering på Kognitive, Fysiske og Fysiologiske Parametre hos Eliteboksere: Et Randomiseret Dobbeltblindet Placebokontrolleret Crossover Studie
Participants will complete six sessions, including one familiarization and baseline session followed by five experimental conditions: control (no supplementation), placebo, L-tyrosine, caffeine, and combined L-tyrosine plus caffeine. The experimental conditions will be performed in a randomized, counterbalanced crossover design with a washout period of at least 72 hours between sessions. Resting physiological and cognitive assessments will be performed during the familiarization session, while biochemical, cognitive, and boxing-specific performance assessments will be conducted before and after each experimental session.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Participants will attend six sessions in total. The first session will be used for familiarization and baseline assessments, including anthropometric measurements, resting physiological measurements, and cognitive performance testing. The remaining five sessions will consist of one control condition (no supplementation) and four randomized experimental conditions (placebo, L-tyrosine, caffeine, and combined L-tyrosine plus caffeine) administered in a randomized, counterbalanced crossover design.
Each experimental session will be separated by a washout period of at least 72 hours. During the placebo, L-tyrosine, caffeine, and combined supplementation conditions, the assigned intervention will be administered 60 minutes before exercise. No supplement will be administered during the control condition.
Before and immediately after each experimental session, venous blood samples will be collected to assess brain-derived neurotrophic factor (BDNF) and oxidative stress biomarkers, including total antioxidant status (TAS), total oxidant status (TOS), malondialdehyde (MDA), superoxide dismutase (SOD), and glutathione peroxidase (GPx). Cognitive performance will be evaluated using the computerized Stroop test, and boxing-specific physical performance will be assessed using a standardized boxing simulation protocol. Heart rate and rating of perceived exertion (RPE) will also be recorded during the exercise protocol.
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Halil UÇAR
- Telefonnummer: +90 5462921133
- E-mail: halil.ucar@inonu.edu.tr
Studiesteder
-
-
-
Erzurum, Tyrkiet (Türkiye)
- Rekruttering
- Ataturk University Faculty of Sport Sciences
-
Kontakt:
- Halil UÇAR
- Telefonnummer: +90 5462921133
- E-mail: halil.ucar@inonu.edu.tr
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
Male elite boxers aged ≥18 years At least 8 years of boxing training experience Active participation in national or international competitions Regular training schedule No injury or illness affecting performance
Exclusion Criteria:
Use of nutritional supplements or stimulants within the last 4 weeks Any cardiovascular, metabolic, or neurological disorder Current injury or musculoskeletal limitation Smoking or excessive caffeine intake Failure to comply with study procedures
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Grundvidenskab
- Tildeling: Randomiseret
- Interventionel model: Crossover opgave
- Maskning: Dobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Placebo komparator: Placebo
Participants receive placebo condition. |
Placebo solution matched in taste and volume to active supplements. |
|
Eksperimentel: L-tyrosine
Participants receive L-tyrosine condition. |
L-tyrosine at 150 mg/kg body weight administered 60 minutes before exercise. |
|
Eksperimentel: Caffeine
Participants receive caffeine condition. |
Caffeine at 5 mg/kg body weight administered 60 minutes before exercise. |
|
Eksperimentel: Combined
Participants receive combined supplementation condition. |
Combined L-tyrosine (150 mg/kg) and caffeine (5 mg/kg) administered 60 minutes before exercise. |
|
Ingen indgriben: Control
Participants complete the experimental protocol without receiving placebo or active supplementation. Baseline cognitive, physiological, and physical performance assessments are performed under the control condition. |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Stroop Test Performance
Tidsramme: up to 12 weeks
|
Cognitive performance assessed using the Stroop test, including reaction time and accuracy. |
up to 12 weeks
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
BDNF Levels
Tidsramme: up to 12 weeks
|
Serum brain-derived neurotrophic factor levels measured before and after exercise. |
up to 12 weeks
|
|
Oxidative Stress Markers
Tidsramme: up to 12 weeks
|
Serum levels of total antioxidant status (TAS), total oxidant status (TOS), malondialdehyde (MDA), superoxide dismutase (SOD) activity, and glutathione peroxidase (GPx) activity will be measured. |
up to 12 weeks
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- UcarPhD2026
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .